Αποτελέσματα Αναζήτησης
For individuals with moderate to severe persistent asthma already taking low- or medium-dose ICS, the preferred treatment is a single inhaler with ICS-formoterol (referred to as single maintenance and reliever therapy, or “SMART”) used both daily and as needed.
2 Ιαν 2020 · This document provides clinical recommendations for the management of severe asthma. Comprehensive evidence syntheses, including meta-analyses, were performed to summarise all available evidence relevant to the European Respiratory Society/American Thoracic Society Task Force's questions.
In keeping with the recommendations from the Asthma Outcomes Workshop (2012), 10 treatment with systemic (oral and parenteral) corticosteroids, asthma-specific emergency department visits, and hospitalizations were included as core outcome measures for exacerbations.
For patients with mild persistent asthma, the Focused Updates recommend either of the following: daily low-dose ICS with as-needed SABA or as-needed ICS with SABA (used one after the other) for...
Patients experiencing an acute severe or life-threatening asthma exacerbation should be referred to the emergency department. 2 Guideline-based emergency evaluation and management of severe asthma exacerbations in adults consists of supplemental oxygen to maintain pulse oximetry at measured oxygen saturation levels of 93% to 95%, 2 short-acting ...
1 Απρ 2024 · The best strategy for management of acute exacerbations of asthma is early recognition and intervention, before attacks become severe and potentially life threatening. Detailed investigations into the circumstances surrounding fatal asthma have frequently revealed failures on the part of both patients and clinicians to recognize the severity of ...
